Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Crawford United Corporation stock logo
CRAWA
Crawford United
$50.00
+3.1%
$49.15
$34.00
$50.00
$177.60M0.76454 shs609 shs
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$3.58
+4.4%
$3.18
$2.37
$7.63
$434.44M1.33834,693 shs862,398 shs
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$10.96
+10.2%
$7.87
$3.91
$13.99
$684.67M1.67822,410 shs1.40 million shs
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
$0.49
-0.4%
$0.54
$0.25
$1.40
$323.97M0.927.13 million shs4.38 million shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Crawford United Corporation stock logo
CRAWA
Crawford United
0.00%0.00%+2.04%+13.64%+42.86%
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
+4.37%-0.83%+0.56%+1.70%-37.63%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
+10.15%+13.46%+22.73%+128.33%+24.97%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
-0.44%+0.61%-6.98%-13.66%+20.24%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Crawford United Corporation stock logo
CRAWA
Crawford United
N/AN/AN/AN/AN/AN/AN/AN/A
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
3.0158 of 5 stars
3.14.00.00.02.24.20.0
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
2.809 of 5 stars
3.53.00.00.03.71.70.0
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
1.5197 of 5 stars
3.81.00.00.01.10.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Crawford United Corporation stock logo
CRAWA
Crawford United
0.00
N/AN/AN/A
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.20
Hold$5.6056.42% Upside
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3.00
Buy$25.67134.18% Upside
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
3.50
Strong Buy$1.70244.83% Upside

Current Analyst Ratings Breakdown

Latest CRAWA, CTKB, SENS, and EYPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/8/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$1.10 ➝ $1.40
6/17/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$28.00
6/2/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy$1.10
5/29/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$22.00
5/28/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $7.00
5/16/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$30.00 ➝ $26.00
5/12/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$3.50 ➝ $3.00
5/9/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$4.00
5/8/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$33.00 ➝ $27.00
4/10/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$2.00
(Data available from 7/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Crawford United Corporation stock logo
CRAWA
Crawford United
$150.20M1.18$5.42 per share9.22$20.44 per share2.45
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$200.45M2.26$0.04 per share98.84$3.07 per share1.17
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$43.27M17.43N/AN/A$4.93 per share2.22
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
$23.68M13.62N/AN/A$0.07 per share7.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Crawford United Corporation stock logo
CRAWA
Crawford United
$13.60M$3.8612.95N/A8.86%19.59%11.96%7/29/2025 (Estimated)
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$6.02M-$0.09N/AN/A-5.71%-2.90%-2.30%8/5/2025 (Estimated)
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$130.87M-$2.41N/AN/AN/A-261.91%-54.27%-41.75%8/6/2025 (Estimated)
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
-$60.39M-$0.11N/AN/AN/A-362.30%-842.25%-67.99%N/A

Latest CRAWA, CTKB, SENS, and EYPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.67N/AN/AN/A$6.82 millionN/A
8/5/2025Q2 2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.02N/AN/AN/A$46.03 millionN/A
5/8/2025Q1 2025
Crawford United Corporation stock logo
CRAWA
Crawford United
$0.96$0.88-$0.08$0.88$41.10 million$43.31 million
5/8/2025Q1 2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.04-$0.09-$0.05-$0.09$43.18 million$41.46 million
5/7/2025Q1 2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.65-$0.65N/A-$0.65$8.84 million$24.50 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Crawford United Corporation stock logo
CRAWA
Crawford United
N/AN/AN/AN/AN/A
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Crawford United Corporation stock logo
CRAWA
Crawford United
0.34
2.19
1.41
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
5.62
4.95
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
7.85
7.79
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
59.17
2.47
2.38

Institutional Ownership

CompanyInstitutional Ownership
Crawford United Corporation stock logo
CRAWA
Crawford United
0.06%
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
12.36%

Insider Ownership

CompanyInsider Ownership
Crawford United Corporation stock logo
CRAWA
Crawford United
37.87%
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
10.33%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
4.46%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
4.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Crawford United Corporation stock logo
CRAWA
Crawford United
4503.55 million2.21 millionNot Optionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
500126.66 million113.58 millionOptionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
12068.81 million65.74 millionOptionable
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
90654.22 million573.90 millionN/A

Recent News About These Companies

Senseonics lays out hopes for next-gen CGM commercial timelines
Senseonics posts Q2 sales beat, submits 365-day CGM for CE mark

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Crawford United stock logo

Crawford United OTCMKTS:CRAWA

$50.00 +1.50 (+3.09%)
As of 07/8/2025 02:39 PM Eastern

Crawford United Corporation, together with its subsidiaries, provides specialty industrial products in the United States, Puerto Rico, Mexico, Canada, and internationally. It operates through two segments: Commercial Air Handling Equipment; and Industrial and Transportation Products. The Commercial Air Handling segment designs, manufactures, and installs large-scale commercial, institutional, and industrial custom air handling solutions to health care, education, pharmaceutical, and industrial manufacturing markets under the FactoryBilt and SiteBilt brand names. The Industrial and Transportation Products segment is involved in the manufacture of flexible interlocking metal hoses primarily to heavy-duty truck manufacturers and aftermarket suppliers, as well as to the agricultural, industrial, and petrochemical markets; and distribution of silicone and hydraulic hoses to the agriculture and general industrial markets. It also provides engineering, machining, grinding, welding, brazing, heat treat, and assembly solutions; rubber and plastic marine hose for the recreational boating industry; engineered manufacturing solutions, including CNC machining, anodizing, electro polishing, and laser marking for defense, aerospace, and medical device markets; and hydraulic hoses, air tank assemblies, and related products to manufacturers of firefighting trucks and other emergency vehicles. In addition, the company engages in the supply of highly engineered forgings for the aerospace, industrial gas turbine, medical prosthetics, alternative energy, petrochemical, and defense industries; and developing and commercializing marketing and data analytic technology applications. The company was formerly known as Hickok Incorporated and changed its name to Crawford United Corporation in May 2019. Crawford United Corporation was founded in 1910 and is headquartered in Cleveland, Ohio.

Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$3.58 +0.15 (+4.37%)
As of 07/9/2025 04:00 PM Eastern

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$10.96 +1.01 (+10.15%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$10.98 +0.02 (+0.23%)
As of 07/9/2025 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Senseonics stock logo

Senseonics NYSE:SENS

$0.49 0.00 (-0.44%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$0.50 +0.01 (+2.43%)
As of 05:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.